Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Mivavotinib

2 clinical trials

5 indications

Indication
Non-GCB/ABC Diffuse Large B-Cell Lymphoma
Indication
MYD88 Mutation
Indication
Malignant Neoplasm
Indication
Ovarian Cancer
Indication
Malignant Solid Neoplasm
Clinical trial
A Phase 2 Study of Mivavotinib in Biomarker-Defined Subgroups of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Terminated, Estimated PCD: 2023-02-24
Clinical trial
A Phase I Study of TAK-659 and Paclitaxel in Patients With Advanced Solid Tumors
Status: Completed, Estimated PCD: 2023-02-23